These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38932817)

  • 1. Non-alcoholic fatty liver disease in obese subjects as related to increasing insulin resistance and deteriorating glucose control: Three years of follow-up from a longitudinal survey.
    Forst T; Botz I; Berse M; Voswinkel S; Strempler ME; Baumann S; Marinez M
    J Diabetes Metab Disord; 2024 Jun; 23(1):999-1006. PubMed ID: 38932817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.
    Rinaldi R; De Nucci S; Castellana F; Di Chito M; Giannuzzi V; Shahini E; Zupo R; Lampignano L; Piazzolla G; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.
    Sanyal D; Mukherjee P; Raychaudhuri M; Ghosh S; Mukherjee S; Chowdhury S
    Indian J Endocrinol Metab; 2015; 19(5):597-601. PubMed ID: 26425466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
    Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease.
    Petralli G; Salvati A; Tricò D; Ricco G; Colombatto P; Brunetto MR; Solini A
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3736. PubMed ID: 37839068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD.
    Guarino G; Strollo F; Della Corte T; Satta E; Gentile S
    Diabetes Ther; 2023 Dec; 14(12):2089-2108. PubMed ID: 37789214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 13. Similar Blood Glucose Pattern with Highest Peak at Minute 45 on Oral Glucose Tolerance Test Despite Higher Fasting Insulin and Insulin Resistance in Healthy Obese than Non-Obese Subject.
    Saraswati MR; Nugraha IBA; Suastika K
    Acta Med Indones; 2022 Apr; 54(2):210-217. PubMed ID: 35818648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
    Lavynenko O; Abdul-Ghani M; Alatrach M; Puckett C; Adams J; Abdelgani S; Alkhouri N; Triplitt C; Clarke GD; Vasquez JA; Li J; Cersosimo E; Gastaldelli A; DeFronzo RA
    Diabetes Obes Metab; 2022 May; 24(5):899-907. PubMed ID: 35014145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Markers in Older Women with a History of Gestational Diabetes and the Effects of Weight Loss.
    Ryan AS
    J Diabetes Res; 2018; 2018():5172091. PubMed ID: 29951553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
    Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
    Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.
    Alam MS; Kamrul-Hasan ABM; Kalam ST; Rahman SMM; Hoque MI; Islam MB; Paul AK
    Diabetes Metab Syndr Obes; 2021; 14():3089-3096. PubMed ID: 34262313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography.
    Wiafe YA; Afihene MY; Anto EO; Nmai RA; Amoah-Kumi L; Frimpong J; Dickson FD; Antwi SO; Roberts LR
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Non-invasive Diagnostic Methods of Liver Fibrosis and Type 2 Diabetes in Pediatric Patients With Non-alcoholic Fatty Liver Disease.
    Yang A; Jung N; Kim S; Lee JE
    Front Pediatr; 2022; 10():825141. PubMed ID: 35223701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.